−£133k
−277%vs Dec 2023Active10117641Private limited companyGrantham
SELENTUS SCIENCE LIMITED
Significant control: John Benjamin Nichols (25–50%), James Benjamin Valentine Walker (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Selentus Science Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Selentus Science Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
SELENTUS SCIENCE LIMITED is an active private limited company (company number 10117641) incorporated on 11 April 2016, registered in Grantham. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2024, showing net assets of −£133k and cash of £35k, with 1 employee on average. Net assets fell 277% on the prior period (£75k).
Peer position · net assets
By net assets it sits in the bottom quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
02
Ownership and control
- Dr John Benjamin Nichols
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr James Benjamin Valentine Walker
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 11 April 201610 yrs ago
- Next accounts due
- 30 September 202625 days overdue
- Confirmation statement due
- 25 April 2027in 182 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£35k
−83%vs Dec 2023Not reported
1
No changevs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | −£133k | £35k | £34k | — | — | — | 1 |
| 31 December 2023 | £75k | £214k | £52k | — | — | — | 1 |
Cash per employee£35kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-133,008 at 31 December 2024
- Net assets down 25% or more on the prior period-276.6% vs prior period
- Incorporated five or more years agoIncorporated 11 April 2016
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 182 days
- Next accounts due25 days overdue
- Accounts period endNet liabilities £133k · small accounts
- Accounts period endNet assets £75k · small accounts
- Incorporated
08
Similar companies in Nottingham
- NESTTECK LTDMansfield · inc. Apr 2016
- EXCELLERATE BIOSCIENCE LIMITEDNottingham · inc. Jun 2016
- BIOSCIENCES BIOSCI LIMITEDNewark · inc. Aug 2016
- WATCH BIDCO LIMITEDNottingham · inc. Nov 2015
- CELLOMATICS BIOSCIENCES LIMITEDColwick · inc. Sept 2015
- QUOTIENT SCIENCES (ALNWICK) LIMITEDNottingham · inc. Sept 2015
All companies incorporated on 11 April 2016 · in Apr 2016.
09
Reminders for SELENTUS SCIENCE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.